Company Filing History:
3 out of 109 
2 out of 138 
1 out of 179 
Years Active: 2017-2023
Title: Gavin Barry Wild: Innovator in Antibody Technology
Introduction
Gavin Barry Wild is a notable inventor based in Slough, GB. He has made significant contributions to the field of antibody technology, holding a total of 6 patents. His work focuses on enhancing the efficacy of recombinant antibody molecules, which are crucial in various therapeutic applications.
Latest Patents
One of his latest patents is titled "Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species." This invention provides a method for increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules. The method involves a thermal conversion step, where the composition is held at a temperature between 30 to 60°C for at least one hour, performed in the presence of a reducing agent or after treatment with one. Another significant patent is the "Method of monomerisation of recombinant antibody molecules." This method also aims to increase the percentage of monomer in a composition of recombinantly expressed antibody molecules, utilizing a denaturant selected from urea and/or Guanidine hydrochloride.
Career Highlights
Gavin has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Srl and UCB Biopharma Sprl. His experience in these organizations has allowed him to refine his expertise in antibody development and innovation.
Collaborations
Throughout his career, Gavin has collaborated with talented individuals such as Sam Philip Heywood and Razwan Hanif. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Gavin Barry Wild is a distinguished inventor whose work in antibody technology has led to several innovative patents. His contributions continue to impact the field significantly, showcasing the importance of research and development in biopharmaceuticals.